Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers.

Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N.

Qual Life Res. 2010 Mar;19(2):177-89. doi: 10.1007/s11136-009-9575-y. Epub 2010 Jan 22.

PMID:
20094806
2.

Wage losses in the year after breast cancer: extent and determinants among Canadian women.

Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N, Brisson J, Mâsse B, Abdous B, Robidoux A, Robert J.

J Natl Cancer Inst. 2008 Mar 5;100(5):321-32. doi: 10.1093/jnci/djn028. Epub 2008 Feb 26.

PMID:
18314472
3.

Quantitative exploration of possible reasons for the recent improvement in breast cancer survival.

Bérubé S, Provencher L, Robert J, Jacob S, Hébert-Croteau N, Lemieux J, Duchesne T, Brisson J.

Breast Cancer Res Treat. 2007 Dec;106(3):419-31. Epub 2007 Feb 1.

PMID:
17268811
4.

Provider's volume and quality of breast cancer detection and treatment.

Hébert-Croteau N, Roberge D, Brisson J.

Breast Cancer Res Treat. 2007 Oct;105(2):117-32. Epub 2006 Dec 21.

PMID:
17186361
5.

Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density.

Diorio C, Bérubé S, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Pollak M, Brisson J.

Cancer Res. 2006 Jan 1;66(1):588-97.

6.

Levels of C-peptide and mammographic breast density.

Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Brisson J.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2661-4.

7.

Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.

Hébert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R.

Cancer. 2005 Oct 1;104(7):1343-8.

8.

Vitamin D and calcium intakes from food or supplements and mammographic breast density.

Bérubé S, Diorio C, Mâsse B, Hébert-Croteau N, Byrne C, Côté G, Pollak M, Yaffe M, Brisson J.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1653-9.

9.

The benefit of participating to clinical research.

Hébert-Croteau N, Brisson J, Lemaire J, Latreille J.

Breast Cancer Res Treat. 2005 Jun;91(3):279-81.

PMID:
15952061
10.

Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.

Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1065-73.

11.

Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.

Théberge I, Hébert-Croteau N, Langlois A, Major D, Brisson J.

CMAJ. 2005 Jan 18;172(2):195-9.

12.

A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer.

Hébert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J.

Breast Cancer Res Treat. 2004 Nov;88(2):187-96.

PMID:
15564801
13.

Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups.

Lauzier S, Maunsell E, De Koninck M, Drolet M, Hébert-Croteau N, Robert J.

Psychooncology. 2005 May;14(5):351-60.

PMID:
15386763
14.

Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.

Hébert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G.

J Clin Oncol. 2004 Sep 15;22(18):3685-93. Epub 2004 Aug 2.

PMID:
15289491
15.

Delay of radiation therapy and outcomes of breast cancer.

Hébert-Croteau N, Freeman C, Latreille J, Brisson J.

J Clin Oncol. 2004 Apr 1;22(7):1342-3; author reply 1343-4. No abstract available.

PMID:
15051786
16.

Delay in adjuvant radiation treatment and outcomes of breast cancer--a review.

Hébert-Croteau N, Freeman CR, Latreille J, Brisson J.

Breast Cancer Res Treat. 2002 Jul;74(1):77-94. Review.

PMID:
12150455
17.

Longer waits for breast cancer surgery in Quebec could be good news.

Hébert-Croteau N, Villeneuve D.

CMAJ. 2001 Nov 13;165(10):1300-1. No abstract available.

18.

Review of organizational factors related to care offered to women with breast cancer.

Hébert-Croteau N, Brisson J, Pineault R.

Epidemiol Rev. 2000;22(2):228-38. Review. No abstract available.

PMID:
11218374
19.

Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994.

Hébert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschênes L.

CMAJ. 1999 Oct 19;161(8):951-5.

20.

Time trends in systemic adjuvant treatment for node-negative breast cancer.

Hébert-Croteau N, Brisson J, Latreille J, Gariépy G, Blanchette C, Deschênes L.

J Clin Oncol. 1999 May;17(5):1458-64.

PMID:
10334531
21.

Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women.

Hébert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschênes L.

Cancer. 1999 Mar 1;85(5):1104-13.

PMID:
10091795
22.

A meta-analysis of hormone replacement therapy and colon cancer in women.

Hébert-Croteau N.

Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):653-9.

23.

Estimation of breast cancer risk by women aged 40 and over: a population-based study.

Hébert-Croteau N, Goggin P, Kishchuk N.

Can J Public Health. 1997 Nov-Dec;88(6):392-6.

PMID:
9458566

Supplemental Content

Loading ...
Support Center